Search

Your search keyword '"SUGIMOTO, M."' showing total 4,392 results

Search Constraints

Start Over You searched for: Author "SUGIMOTO, M." Remove constraint Author: "SUGIMOTO, M."
4,392 results on '"SUGIMOTO, M."'

Search Results

2. The accomplishment of the Engineering Design Activities of IFMIF/EVEDA: The European Japanese project towards a Li(d,xn) fusion relevant neutron source

3. IFMIF/EVEDA achievements overview

5. Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema in Eyes with Branch Retinal Vein Occlusion with vs Without Glaucoma – Does Glaucoma Affect Visual Outcome in Eyes with BRVO-ME After antiVEGF Injections?

7. Observing the Sun with the Atacama Large Millimeter-submillimeter Array (ALMA): Fast-Scan Single-Dish Mapping

8. Observing the Sun with Atacama Large Millimeter/submillimeter Array (ALMA): High Resolution Interferometric Imaging

10. Comparison of Exhaled Volatile Organic Compounds Among Severe Asthma Phenotypes in Japan: A J-VOCSA Study

11. Long-term outcomes of a multicenter prospective observational study of active surveillance for early-stage prostate cancer: The PRIAS-JAPAN study

13. Positive Culture Prior to Transperineal Prostate Biopsy Was Not Associated with Post-Biopsy Febrile Urinary Tract Infection Development

16. Laser Thomson scattering system for anisotropic electron temperature measurement in NUMBER

17. An Overview of the 2014 ALMA Long Baseline Campaign

19. Clarification as to why alcoholic beverages have the ability to induce superconductivity in Fe_{1+d}Te_{1-x}S_x

28. Concept of Staged Approach for International Fusion Materials Irradiation Facility

29. Noise Performance Improvements of 2-Layer Transistor Pixel Stacked CMOS Image Sensor with Non-doped Pixel-FinFETs

37. Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial

44. 157O Biomarker analysis and updated results from the phase III PROpel trial of abiraterone (abi) and olaparib (ola) vs abi and placebo (pbo) as first-line (1L) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

45. 1357O Biomarker analysis and updated results from the Phase III PROpel trial of abiraterone (abi) and olaparib (ola) vs abi and placebo (pbo) as first-line (1L) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

47. 1963O JCOG1019: An open-label, non-inferiority, randomised phase III study comparing the effectiveness of watchful waiting (WW) and intravesical Bacillus Calmette-Guérin (BCG) in patients (Pts) with high-grade pT1 (HGT1) bladder cancer with pT0 on the second transurethral resection (TUR) specimen

Catalog

Books, media, physical & digital resources